169 related articles for article (PubMed ID: 38398573)
1. Computer-Aided Strategy on 5-(Substituted benzylidene) Thiazolidine-2,4-Diones to Develop New and Potent PTP1B Inhibitors: QSAR Modeling, Molecular Docking, Molecular Dynamics, PASS Predictions, and DFT Investigations.
Derki NH; Kerassa A; Belaidi S; Derki M; Yamari I; Samadi A; Chtita S
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398573
[TBL] [Abstract][Full Text] [Related]
2. In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors.
Mahapatra MK; Bera K; Singh DV; Kumar R; Kumar M
J Biomol Struct Dyn; 2018 Apr; 36(5):1195-1211. PubMed ID: 28393626
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.
Aouidate A; Ghaleb A; Ghamali M; Ousaa A; Choukrad M; Sbai A; Bouachrine M; Lakhlifi T
Comput Biol Chem; 2018 Jun; 74():201-211. PubMed ID: 29635214
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
[TBL] [Abstract][Full Text] [Related]
6. New chromone derivatives bearing thiazolidine-2,4-dione moiety as potent PTP1B inhibitors: Synthesis and biological activity evaluation.
Zheng Y; Lu L; Li M; Xu D; Zhang L; Xiong Z; Zhou Y; Li J; Xu X; Zhang K; Xu L
Bioorg Chem; 2024 Feb; 143():106985. PubMed ID: 38007892
[TBL] [Abstract][Full Text] [Related]
7. An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.
Biharee A; Singh Y; Kulkarni S; Jangid K; Kumar V; Jain AK; Thareja S
J Mol Graph Model; 2024 Mar; 127():108695. PubMed ID: 38118354
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
Mahapatra MK; Kumar R; Kumar M
Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
[TBL] [Abstract][Full Text] [Related]
9. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation and molecular dynamics studies of 4-thiazolinone derivatives as protein tyrosine phosphatase 1B (PTP1B) inhibitors.
Liu WS; Wang RR; Yue H; Zheng ZH; Lu XH; Wang SQ; Dong WL; Wang RL
J Biomol Struct Dyn; 2020 Aug; 38(13):3814-3824. PubMed ID: 31490104
[TBL] [Abstract][Full Text] [Related]
11. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL
Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135
[TBL] [Abstract][Full Text] [Related]
13. Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors.
Zhang X; Mao J; Li W; Koike K; Wang J
Comput Biol Chem; 2019 Dec; 83():107134. PubMed ID: 31629257
[TBL] [Abstract][Full Text] [Related]
14. Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.
Patel P; Patel VK; Singh A; Jawaid T; Kamal M; Rajak H
Curr Comput Aided Drug Des; 2019; 15(2):145-166. PubMed ID: 29732991
[TBL] [Abstract][Full Text] [Related]
15. Potential Therapeutic Target Protein Tyrosine Phosphatase-1B for Modulation of Insulin Resistance with Polyphenols and Its Quantitative Structure-Activity Relationship.
Rath P; Ranjan A; Ghosh A; Chauhan A; Gurnani M; Tuli HS; Habeeballah H; Alkhanani MF; Haque S; Dhama K; Verma NK; Jindal T
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408611
[TBL] [Abstract][Full Text] [Related]
16. New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies.
Elkady H; Abuelkhir AA; Rashed M; Taghour MS; Dahab MA; Mahdy HA; Elwan A; Al-Ghulikah HA; Elkaeed EB; Ibrahim IM; Husein DZ; Metwaly A; Eissa IH
Comput Biol Chem; 2023 Dec; 107():107958. PubMed ID: 37714080
[TBL] [Abstract][Full Text] [Related]
17. Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies.
Abchir O; Daoui O; Belaidi S; Ouassaf M; Qais FA; ElKhattabi S; Belaaouad S; Chtita S
J Mol Model; 2022 Mar; 28(4):106. PubMed ID: 35352175
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Choubey SK; Jeyaraman J
J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
[TBL] [Abstract][Full Text] [Related]
20. A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.
Izadpanah E; Riahi S; Abbasi-Radmoghaddam Z; Gharaghani S; Mohammadi-Khanaposhtanai M
Mol Divers; 2021 Aug; 25(3):1811-1825. PubMed ID: 33565001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
